z-logo
Premium
Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?
Author(s) -
Wei Jianlu,
Buza John,
Liu Chuanju
Publication year - 2016
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.23091
Subject(s) - anakinra , etanercept , medicine , infliximab , osteoarthritis , adalimumab , tumor necrosis factor alpha , receptor , interleukin , cartilage , cytokine , inflammation , arthritis , synovial fluid , immunology , pathology , disease , anatomy , alternative medicine

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom